Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Prasco Laboratories
CINCINNATI, Oct. 17, 2013 /PRNewswire/ -- Prasco Laboratories announced today it has signed an exclusive distribution and supply agreement with Shire for the Authorized Generic of FOSRENOL® (lanthanum carbonate) Chewable Tablets. As part of the agreement, Prasco will market Lanthanum Carbonate Chewable Tablets in the U.S. in 500 mg, 750 mg, and 1000 mg strengths under the Prasco label in response to the first generic entrant.
"Today's announcement is the latest example of Prasco and Shire working together to continue providing high-quality prescription options to consumers," stated Prasco president and chief operating officer David Vucurevich, R.Ph. "Patients and customers alike benefit from Shire's commitment to maintaining the supply of brand-identical medication through the Prasco Authorized Generic business model," Vucurevich concluded.
Lanthanum Carbonate Chewable Tablets are AB-rated and substitutable for the brand FOSRENOL Chewable Tablets. FOSRENOL is a phosphate binder indicated to reduce serum phosphate in patients with end stage renal disease (ESRD). For more information on Lanthanum Carbonate Chewable Tablets, including the Full Prescribing Information, visit prasco.com. Please click here for Full Prescribing Information for FOSRENOL (lanthanum carbonate)
About Prasco Laboratories – Prasco, the Authorized Generic Company, is the privately held healthcare company located in Mason, Ohio. The leader in Authorized Generics, Prasco has more Authorized Generic partnerships than any other company. Established brand companies rely on Prasco to bring their brand products to the generic marketplace as Authorized Generics, which offers alternatives to consumers and pharmacists. For more information, visit prasco.com.
IMPORTANT SAFETY INFORMATION
FOSRENOL is a trademark of Shire LLC.
©2012 PR Newswire. All Rights Reserved.